Re: Re: Neonatal HIV 30 September 2004
Previous Rapid Response Next Rapid Response Top
Mark Bartlett,
CD Investigator
Canada

Send response to journal:
Re: Re: Re: Neonatal HIV

To Christopher Tyler,

Nice overview of studies that question the use of AZT to reduce pre- natal HIV transmission. I might add that study ACTG076 -- the "hallmark study" and one of the few that seems to support its use, was sponsored by the drug company that makes AZT.

I recently heard that some journals, including (I believe) The New England Journal of Medicine, Lancet and the Canadian Medical Association Journal, are no longer going to publish papers unless ALL the data is provided by the authors for their scrutiny.

One has to wonder about the integrity of science when journals like these have to take those kinds of steps -- very sad!

Competing interests: None declared